Finance

Lists
RMD:ASX
Resmed CDI
A$ ३४.२०
+०.३८%
(+०.१३) 1D
अक्टोबर २०, १६:१४:५५ GMT+११  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
A$ ३३.९३
High
A$ ३४.३८
Low
A$ ३३.८६
Mkt. cap
३४.५३ अरब
Avg. vol.
१०.५३ लाख
Volume
१४.६७ लाख
52-wk high
A$ ४१.५४
52-wk low
A$ २५.५०
Shares outstanding
१४.०६ करोड
No. of employees
११ हजार
Open
A$ ३३.९३
High
A$ ३४.३८
Low
A$ ३३.८६
Mkt. cap
३४.५३ अरब
Avg. vol.
१०.५३ लाख
Volume
१४.६७ लाख
52-wk high
A$ ४१.५४
52-wk low
A$ २५.५०
Shares outstanding
१४.०६ करोड
No. of employees
११ हजार
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
२ घण्टा पहिले
Mizuho lifts target for ResMed stock to USD 240.00
Simply Wall Street
Simply Wall Street
·
५ घण्टा पहिले
New Mask Launch Could Be A Big Test For ResMed Stock
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees११.४ हजार
Foundedजुन १९८९
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Websiteresmed.com
Next call ९ दिनमा
अक्टोबर २९, बिहि, २२:३०
Fiscal period
Q1 2027
- / US$ ०.२७
Revenue / Est. (USD)
- / १.३९ अरब
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.३४ अरब
१.४२ अरब
१.४३ अरब
१.४६ अरब
Cost of goods sold
५०.६९ करोड
५३.६३ करोड
५३.२६ करोड
५९.४१ करोड
Cost of revenue
५०.६९ करोड
५३.६३ करोड
५३.२६ करोड
५९.४१ करोड
Research and development expenses
८.७३ करोड
९.१० करोड
९.४३ करोड
१०.५७ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२५.९२ करोड
२७.५७ करोड
२७.९८ करोड
२९.३४ करोड
Operating expense
३६.६३ करोड
३८.६२ करोड
३९.३२ करोड
४१.७९ करोड
Total operating expenses
८७.३२ करोड
९२.२५ करोड
९२.५७ करोड
१.०१ अरब
Operating income
४६.२३ करोड
५०.०३ करोड
५०.५७ करोड
४५.१६ करोड
Other non operating income
-३८.३६ लाख
४२.०० हजार
१.८१ लाख
४४.०२ लाख
EBT including unusual items
४४.६८ करोड
४९.६१ करोड
५०.२३ करोड
४७.४२ करोड
EBT excluding unusual items
४६.८८ करोड
५०.४५ करोड
५१.८३ करोड
४७.६१ करोड
Income tax expense
९.८३ करोड
१०.३६ करोड
१०.३६ करोड
९.०७ करोड
Effective tax rate
२१.९९%
२०.८७%
२०.६२%
१९.१४%
Other operating expenses
-
-
-
-
Net income
३४.८५ करोड
३९.२६ करोड
३९.८७ करोड
३८.३४ करोड
Net profit margin
२६.१०%
२७.५९%
२७.८६%
२६.२०%
Earnings per share
२.५५
२.८१
०.२९
०.३०
Interest and investment income
४६.८६ लाख
४४.५९ लाख
३८.०४ लाख
३.१८ करोड
Interest expense
-
-
-
-
Net interest expenses
४६.८६ लाख
४४.५९ लाख
३८.०४ लाख
३.१८ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
५०.३६ करोड
५४.३८ करोड
५५.८२ करोड
४९.०१ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू